m+Medelevator.RU
← Поиск публикаций
International journal of surgery case reports · 2025

Endobronchial solitary fibrous tumor: A case report with comprehensive literature review.

Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Jalil Riad Abdel, Alshwayyat Sakhr, Haddad Hussam, Al-Kurdi Mohammed Al-Mahdi

Аннотация

INTRODUCTION AND IMPORTANCE: Endobronchial solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that account for less than 2 % of all SFTs. Diagnosis and treatment are major challenges because of their rarity and varied presentation. We present a case of endobronchial SFT that was successfully treated with minimally invasive bronchoscopic excision and review the literature to highlight the latest developments in diagnosis and treatment.

CASE PRESENTATION: A 45-year-old female was referred for an incidental finding of bronchial lesion on imaging. Chest computed tomography (CT) revealed a well-defined, noncalcified, obstructive lesion in the left upper lobe bronchus. Flexible bronchoscopy confirmed complete airway obstruction, and the tumor was excised using a hot snare. Histopathological examination revealed a low-risk solitary fibrous tumor with immunohistochemical positivity for CD34 and Bcl-2, confirming SFT. Follow-up imaging and clinical follow-up for three years showed no recurrence.

CLINICAL DISCUSSION: We highlight the relevance of advanced imaging, histopathological examination, and multimodal management for the diagnosis and treatment of endobronchial SFTs. Minimally invasive bronchoscopic excision is a safe and effective treatment modality for localized lesions.

CONCLUSION: This literature review underlines the need for long-term surveillance because of the tendency for malignant transformation. Documenting these infrequent cases improves diagnostic and therapeutic strategies for endobronchial SFTs.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты